Bloomberg Intelligence cover image

AT&T to Buy EchoStar Spectrum Licenses for About $23 Billion

Bloomberg Intelligence

00:00

Eli Lilly's Game Changer: The Weight Loss Pill

This chapter explores Eli Lilly's weight loss pill's clinical trial results, highlighting a significant 10% weight reduction in obese diabetics and the challenges faced by participants. It further examines the implications of these findings for market competitiveness and the broader biotech sector, including trends in mergers and acquisitions.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app